Research ArticleArticle
Are Baseline High Molecular Weight Adiponectin Levels Associated with Radiographic Progression in Rheumatoid Arthritis and Osteoarthritis?
Inge R. Klein-Wieringa, Stefan N. Andersen, Linda Herb-van Toorn, Joanneke C. Kwekkeboom, Anette H.M. van der Helm-van Mil, Ingrid Meulenbelt, Tom W.J. Huizinga, Margreet Kloppenburg, René E.M. Toes and Andreea Ioan-Facsinay
The Journal of Rheumatology April 2014, jrheum.130888; DOI: https://doi.org/10.3899/jrheum.130888
Inge R. Klein-Wieringa
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Stefan N. Andersen
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Linda Herb-van Toorn
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Joanneke C. Kwekkeboom
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Anette H.M. van der Helm-van Mil
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Ingrid Meulenbelt
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Tom W.J. Huizinga
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Margreet Kloppenburg
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
René E.M. Toes
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Andreea Ioan-Facsinay
From the Department of Rheumatology, and the Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Supported by TI-Pharma, EU FP6 program Autocure, FP7 program Masterswitch, a grant from Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative, and the Netherlands. I.R. Klein-Wieringa, MD; S.N. Andersen, Analyst; L. Herb-vam Toorn, Analyst; J.C. Kwekkeboom, Analyst; A.H.M. van der Helm-van Mil, MD, PhD, Head of the Outpatient Clinic, Department of Rheumatology, Leiden University Medical Center; I. Meulenbelt, PhD, Associate Professor, Department of Molecular Epidemiology, Leiden; T.W.J. Huizinga, MD, PhD, Professor; M. Kloppenburg, MD, PhD, Professor; R.E.M. Toes, PhD, Professor; A. Ioan-Facsinay, PhD, Assistant Professor. Address correspondence to Dr. A. Ioan-Facsinay, Dept. of Rheumatology, C1-R, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail: A.ioan@lumc.nl. Accepted for publication January 31, 2014.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Are Baseline High Molecular Weight Adiponectin Levels Associated with Radiographic Progression in Rheumatoid Arthritis and Osteoarthritis?
Inge R. Klein-Wieringa, Stefan N. Andersen, Linda Herb-van Toorn, Joanneke C. Kwekkeboom, Anette H.M. van der Helm-van Mil, Ingrid Meulenbelt, Tom W.J. Huizinga, Margreet Kloppenburg, René E.M. Toes, Andreea Ioan-Facsinay
The Journal of Rheumatology Apr 2014, jrheum.130888; DOI: 10.3899/jrheum.130888
Are Baseline High Molecular Weight Adiponectin Levels Associated with Radiographic Progression in Rheumatoid Arthritis and Osteoarthritis?
Inge R. Klein-Wieringa, Stefan N. Andersen, Linda Herb-van Toorn, Joanneke C. Kwekkeboom, Anette H.M. van der Helm-van Mil, Ingrid Meulenbelt, Tom W.J. Huizinga, Margreet Kloppenburg, René E.M. Toes, Andreea Ioan-Facsinay
The Journal of Rheumatology Apr 2014, jrheum.130888; DOI: 10.3899/jrheum.130888